Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00971906
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 660
Testing effectiveness (Phase 2)Study completedNCT01353534
What this trial is testing

Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine

Who this might be right for
Healthy
Intercell USA, Inc. 276
Post-approval studies (Phase 4)Study completedNCT01511744
What this trial is testing

Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine

Who this might be right for
Human Influenza
Hualan Biological Engineering, Inc. 6,000
Early research (Phase 1)Study completedNCT01701752
What this trial is testing

Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults

Who this might be right for
Influenza A
Immune Targeting Systems Ltd 120
Large-scale testing (Phase 3)Study completedNCT02263131
What this trial is testing

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children

Who this might be right for
Healthy
Il-Yang Pharm. Co., Ltd. 416
Testing effectiveness (Phase 2)Study completedNCT00956202
What this trial is testing

Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 303
Early research (Phase 1)Study completedNCT00240903
What this trial is testing

Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 37
Large-scale testing (Phase 3)Study completedNCT05779020
What this trial is testing

Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

Who this might be right for
Influenza, Human
Butantan Institute 1,373
Early research (Phase 1)Study completedNCT00906750
What this trial is testing

A Live Intranasal Influenza Vaccine in Children With Cancer

Who this might be right for
Cancer
St. Jude Children's Research Hospital 56
Testing effectiveness (Phase 2)Study completedNCT00115986
What this trial is testing

A/H5N1in Adult - Aventis

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 452
Testing effectiveness (Phase 2)Study completedNCT00424086
What this trial is testing

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 1,000
Post-approval studies (Phase 4)Study completedNCT03020498
What this trial is testing

B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)

Who this might be right for
Influenza
Stanford University 91
Large-scale testing (Phase 3)Study completedNCT06641180
What this trial is testing

Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 1,180
Testing effectiveness (Phase 2)Study completedNCT00936468
What this trial is testing

Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects

Who this might be right for
Influenza
Colby Pharmaceutical Company 472
Testing effectiveness (Phase 2)Study completedNCT00524940
What this trial is testing

Trial to Describe the Safety and Immunogenicity of Fluzone®

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 124
Post-approval studies (Phase 4)Study completedNCT01758185
What this trial is testing

Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine

Who this might be right for
Healthy
Beijing Center for Disease Control and Prevention 3,308
Testing effectiveness (Phase 2)Study completedNCT00905125
What this trial is testing

Influenza Vaccine in Pregnant Women

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 102
Testing effectiveness (Phase 2)WithdrawnNCT00342940
What this trial is testing

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Who this might be right for
Influenza
Novartis
Post-approval studies (Phase 4)Study completedNCT04559204
What this trial is testing

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Who this might be right for
Influenza, HumanPneumonia, Pneumococcal
China National Biotec Group Company Limited 1,224
Large-scale testing (Phase 3)Study completedNCT04101435
What this trial is testing

Immunogenicity and Safety Evaluation of QIS in Healthy Subjects

Who this might be right for
Influenza
Adimmune Corporation 174
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation